HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours
about
The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase IIThe parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogeneThe tumor suppressor Cdc73 functionally associates with CPSF and CstF 3' mRNA processing factorsThe parafibromin tumor suppressor protein is part of a human Paf1 complexEndocrine neoplasms in familial syndromes of hyperparathyroidismParathyroid cancerGenetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumorsParafibromin, a component of the human PAF complex, regulates growth factors and is required for embryonic development and survival in adult miceGenomic profiling reveals mutational landscape in parathyroid carcinomasParafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression.The parafibromin tumor suppressor protein interacts with actin-binding proteins actinin-2 and actinin-3.Human synthetic lethal inference as potential anti-cancer target gene detectionThe tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression.Parathyroid carcinoma in pregnancy.Parathyroid carcinoma: a silent presentationFine-needle aspiration cytology of parathyroid carcinoma mimic hürthle cell thyroid neoplasmClinical and molecular genetics of parathyroid neoplasmsGenetic characterization of large parathyroid adenomasWhole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas.CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinomaNovel HRPT2/CDC73 gene mutations and loss of expression of parafibromin in Chinese patients with clinically sporadic parathyroid carcinomasGenome-wide and locus specific alterations in CDC73/HRPT2-mutated parathyroid tumors.Hyperparathyroidism-jaw tumor syndrome: Results of operative management.Parathyroid cancer.Defective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism-jaw tumor syndrome.Primary hyperparathyroidism: an overview.Parathyroid carcinoma: a review with three illustrative cases.Parathyroid carcinoma: current understanding and new insights into gene expression and intraoperative parathyroid hormone kineticsA Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice.Rapid mutation screening for HRPT2 and MEN1 mutations associated with familial and sporadic primary hyperparathyroidism.The Roles of the Paf1 Complex and Associated Histone Modifications in Regulating Gene ExpressionDiagnostic performance of parafibromin immunohistochemical staining for sporadic parathyroid carcinoma: a meta-analysis.Downregulated parafibromin expression is a promising marker for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.Metastatic calcifications and severe hypercalcemia in a patient with parathyroid carcinoma.Allelic imbalance in sporadic parathyroid carcinoma and evidence for its de novo origins.Significance of Parafibromin Expression in Laryngeal Squamous Cell CarcinomasNon-functional parathyroid carcinoma: a review of the literature and report of a case requiring extensive surgery.Dephosphorylated parafibromin is a transcriptional coactivator of the Wnt/Hedgehog/Notch pathways.Hyperparathyroidism 2 gene (HRPT2, CDC73) and parafibromin studies in two patients with primary hyperparathyroidism and uncertain pathological assessmentCDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer.
P2860
Q24304135-ED427134-422C-46B6-B828-144FBE26E90AQ24312426-23DCF3D0-840A-4274-B0BF-9CE0EFDC9F5EQ24315774-CAF7CDE1-60A6-4756-A016-F790875A7EDEQ24557571-B625DDD5-ABF2-4321-9088-98127C755BB0Q26747174-9CDA3CEA-AB99-4340-95FD-6EFA6F5483F0Q26796612-D368FDE7-D8CE-45A1-B39F-C859998FE299Q27025359-6B3C14B5-3E5E-4C78-98F3-F4F499462D2EQ28592704-C4999448-6158-42E9-8DB3-3A2550F9194BQ30360213-81F272D5-4DAE-49F6-BBF7-E28452E38030Q33209570-DD6EBFCF-92CE-43DC-AA76-9D8205760C9EQ33358543-0D246481-3C33-4833-8896-FDF8B4A100CDQ33518904-66F3E4CE-77AA-4FA9-ABED-7FF42834B833Q33608914-014E6391-720A-4761-886E-CF8D03A93F3AQ33621201-B1C6B52B-C867-4AD7-A397-B3E97A05C967Q34070041-D01D18B5-5268-487A-B327-A776367AD045Q34080468-E4DD15F0-BE18-441A-AEF8-6077575979D5Q34125668-6C5CEB56-901D-4944-8FC7-C0E140D1D69AQ34264055-D89B05C0-0231-4E85-B1EA-7A127B6E3554Q34362269-2EFE3EB6-EC7F-4953-AA2F-51ED23082A00Q34396517-C3FA6C61-500E-4C55-A786-E328F3970810Q34429448-0E522ADE-5774-4B1F-94A3-8F5C2F726E04Q34431091-F5159554-7296-481E-A9F4-FCD6E12FD27CQ34630850-380B2DAD-20BF-4DB7-BDDC-AB184AEF9D98Q34686824-DC92F113-4040-4CEE-9AC1-9275FA3CD4CFQ34993892-7EB3098C-9392-43BA-B3DF-18EFB1A45D8EQ35071213-0BD3587A-EDD0-4983-8141-3DFF131E3322Q35479870-D48AB0ED-6CB9-4EA3-9651-41621BA88E2AQ35583695-E3E958A1-FAE4-41F5-A4F0-BB75362DFAB9Q35755034-E3ABBA1F-D140-4D13-88DF-B305FB717434Q35807875-B3EE95C5-052D-4206-934A-B3F23EBABD6DQ35811839-FAA49E61-5A9E-404F-BEF3-1EEA58DE43A8Q36037109-0B8BC3D3-6A45-4D61-BCB5-6E96964A9CF2Q36444814-B490376C-5CAE-4AB5-BA3B-DBED813AFB79Q36587366-DE31795C-55C5-4E89-A8B3-A39BBDE394A2Q36931408-F607CB93-D91C-4562-8A86-07CB0FA391FBQ37133266-9F05CAA6-B299-438F-A2DB-D61FCAE56089Q37274291-5C6C6F4B-4965-44B3-B525-48258300D682Q37281851-C571389C-9AD2-4ED3-8944-A3B204346836Q37353629-C560AF83-FAB2-44D5-B3B6-8233BAAB4050Q37358248-890F8F49-63C5-43B9-88B6-56C8AA461527
P2860
HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours
@ast
HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours
@en
HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours
@nl
type
label
HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours
@ast
HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours
@en
HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours
@nl
prefLabel
HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours
@ast
HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours
@en
HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours
@nl
P2093
P2860
P3181
P356
P1476
HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours
@en
P2093
A E Nelson
B G Robinson
C Hoang-Vu
G J Fleuren
P2860
P304
P3181
P356
10.1136/JMG.40.9.657
P407
P50
P577
2003-09-01T00:00:00Z